0001592473-16-000007.txt : 20161107
0001592473-16-000007.hdr.sgml : 20161107
20161107145711
ACCESSION NUMBER: 0001592473-16-000007
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20161107
DATE AS OF CHANGE: 20161107
EFFECTIVENESS DATE: 20161107
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Brookhaven Medical, Inc.
CENTRAL INDEX KEY: 0001592473
IRS NUMBER: 900959093
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-273945
FILM NUMBER: 161977745
BUSINESS ADDRESS:
STREET 1: 3424 PEACHTREE ROAD, NW
STREET 2: SUITE 1150
CITY: ATLANTA
STATE: GA
ZIP: 30326
BUSINESS PHONE: 404-205-8282
MAIL ADDRESS:
STREET 1: 3424 PEACHTREE ROAD, NW
STREET 2: SUITE 1150
CITY: ATLANTA
STATE: GA
ZIP: 30326
FORMER COMPANY:
FORMER CONFORMED NAME: Brookhaven Medical,Inc
DATE OF NAME CHANGE: 20131120
D
1
primary_doc.xml
X0707
D
LIVE
0001592473
Brookhaven Medical, Inc.
3424 PEACHTREE ROAD, NE
SUITE 1150
ATLANTA
GA
GEORGIA
30326
404-205-8282
DELAWARE
Brookhaven Medical,Inc
Corporation
true
2013
John
D.
Feltman
3424 Peachtree Road, NE
Suite 1150
Atlanta
GA
GEORGIA
30326
Executive Officer
Director
Stephen
Warner
3424 Peachtree Road, NE
Suite 1150
Atlanta
GA
GEORGIA
30326
Director
James
S.
Johnson
3424 Peachtree Road, NE
Suite 1150
Atlanta
GA
GEORGIA
30326
Director
Allen
B.
Boswell
3424 Peachtree Road, NE
Suite 1150
Atlanta
GA
GEORGIA
30326
Director
John
Ramey
3424 Peachtree Road, NE
Suite 1150
Atlanta
GA
GEORGIA
30326
Director
Robert
E.
Altenbach
3424 Peachtree Road, NE
Suite 1150
Atlanta
GA
GEORGIA
30326
Executive Officer
Marc
Morin
3424 Peachtree Road, NE
Suite 1150
Atlanta
GA
GEORGIA
30326
Executive Officer
Scott
C.
Jones
3424 Peachtree Road, NE
Suite 1150
Atlanta
GA
GEORGIA
30326
Executive Officer
Other Health Care
$25,000,001 - $100,000,000
- 06b
false
2016-10-24
false
true
true
false
25000
10000000
300000
9700000
The Issuer is offering up to $10,000,000 in principal amount of 8% convertible notes. The Form D is also intended to cover the underlying shares of common stock.
false
3
800000
true
0
The Issuer may engage broker-dealers to offer and sell the 8% convertible notes, who may be paid commissions up to 8% of the principal amount of the notes.
0
false
Brookhaven Medical, Inc.
/s/ John D. Feltman
John D. Feltman
Chairman and Chief Executive Officer
2016-11-07